![K&L Gates LLP](/img/client_headers/KLGates/Header.jpg)
In this episode, Erica Jackson discusses recent guidance from the Food & Drug Administration (FDA) on the consideration of real-world data and real-world evidence in regulatory decision-making related to medical devices and their development. The episode notes stakeholders should work closely with the FDA so that real-world data collected and maintained during the development process is high quality, relevant, reliable, and stored with the appropriate privacy and data security protections.